These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28687988)

  • 1. Initial and late efficacy of everolimus-eluting stents for small and non-small coronary lesions from evaluating delayed late loss study.
    Tama N; Uzui H; Horita Y; Namura M; Tada H
    Heart Vessels; 2017 Dec; 32(12):1415-1423. PubMed ID: 28687988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year clinical outcomes of the NOBORI biolimus-eluting stents versus XIENCE/PROMUS everolimus-eluting stents in small vessel disease.
    Jinnouchi H; Kuramitsu S; Shinozaki T; Hiromasa T; Kobayashi Y; Morinaga T; Yamaji K; Soga Y; Shirai S; Ando K
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):E132-E138. PubMed ID: 26708085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical outcomes of coronary artery stent implantation in patients with end-stage chronic kidney disease including hemodialysis for three everolimus eluting (EES) stent designs: Bioresorbable polymer-EES, platinum chromium-EES, and cobalt chrome-EES.
    Sato T; Hatada K; Kishi S; Fuse K; Fujita S; Ikeda Y; Takahashi M; Matsubara T; Okabe M; Aizawa Y
    J Interv Cardiol; 2018 Apr; 31(2):170-176. PubMed ID: 29166699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES VI trial.
    Kang DY; Lee CH; Lee PH; Ahn JM; Lee SW; Kim YH; Park SW; Nam CW; Choi YS; Rha SW; Cho JH; Kim W; Her SH; Jeong MH; Yang JY; Lee BK; Park HS; Park DW; Park SJ
    Coron Artery Dis; 2019 Jan; 30(1):59-66. PubMed ID: 30507632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of everolimus-eluting stent implantation in patients with small coronary arteries (≤2.5 mm): outcomes of 3-year clinical follow-up.
    Yano H; Horinaka S; Ishikawa M; Ishimitsu T
    Heart Vessels; 2017 Jul; 32(7):796-803. PubMed ID: 28025695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Efficacy of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With In-Stent Restenosis (from the RIBS IV and V Randomized Clinical Trials).
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; Masotti M; López-Minguez JR; Iñiguez A; Zueco J; Velazquez M; Cequier A; Lázaro-García R; Martí V; Moris C; Urbano-Carrillo C; Bastante T; Rivero F; Cárdenas A; Gonzalo N; Jiménez-Quevedo P; Fernández C;
    Am J Cardiol; 2016 Feb; 117(4):546-554. PubMed ID: 26725102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
    Puricel S; Arroyo D; Corpataux N; Baeriswyl G; Lehmann S; Kallinikou Z; Muller O; Allard L; Stauffer JC; Togni M; Goy JJ; Cook S
    J Am Coll Cardiol; 2015 Mar; 65(8):791-801. PubMed ID: 25720622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
    Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K
    Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-Year Clinical and Angiographic Outcomes After Everolimus-Eluting Stent Implantation in Patients With a History of Coronary Artery Bypass Grafting.
    Nomura T; Suzuki N; Takamura S; Kyono H; Kozuma K
    Int Heart J; 2016; 57(2):158-66. PubMed ID: 26973268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: a randomized comparison in setting of ISAR-TEST-4 trial.
    Kufner S; Byrne RA; Mehilli J; Massberg S; Birkmeier KA; Schulz S; Pache J; Schömig A; Kastrati A
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E769-76. PubMed ID: 23754254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries.
    Yoshida T; Sakata K; Nitta Y; Taguchi T; Kaku B; Katsuda S; Shimojima M; Gamou T; Nakahashi T; Konno T; Kawashiri MA; Yamagishi M; Hayashi K
    Heart Vessels; 2016 May; 31(5):635-42. PubMed ID: 25758470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midterm angiographic outcomes with sirolimus- and everolimus-eluting stents for small vessels in diabetic patients: propensity-score-matched comparisons in three different vessel diameters.
    Suzuki K; Ishikawa T; Mutoh M; Sakamoto H; Kubota T; Ogawa T; Mori C; Hashimoto K; Komukai K; Yoshimura M;
    Cardiovasc Interv Ther; 2018 Jul; 33(3):205-216. PubMed ID: 28349417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 2-year outcomes between zotarolimus-eluting and everolimus-eluting new-generation cobalt-chromium alloy stents in real-world diabetic patients.
    Miyazaki T; Latib A; Panoulas VF; Miyazaki S; Costopoulos C; Sato K; Naganuma T; Kawamoto H; Daida H; Colombo A
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):E11-8. PubMed ID: 25534499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal threshold of postintervention minimum stent area to predict in-stent restenosis in small coronary arteries: An optical coherence tomography analysis.
    Matsuo Y; Kubo T; Aoki H; Satogami K; Ino Y; Kitabata H; Taruya A; Nishiguchi T; Teraguchi I; Shimamura K; Shiono Y; Orii M; Yamano T; Tanimoto T; Yamaguchi T; Hirata K; Tanaka A; Akasaka T
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):E9-E14. PubMed ID: 26268150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity-Score Matched Comparison of Midterm Angiographic Outcomes of Sirolimus- Versus Everolimus- and Biolimus-Eluting Stents for De Novo Coronary Stenosis.
    Suzuki K; Ishikawa T; Mutoh M; Sakamoto H; Mori C; Ogawa T; Hashimoto K; Kubota T; Komukai K; Yoshimura M;
    Int Heart J; 2017 May; 58(3):320-327. PubMed ID: 28484124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
    Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusion (ACE-CTO) Study.
    Kotsia A; Navara R; Michael TT; Sherbet DP; Roesle M; Christopoulos G; Rangan BV; Haagen D; Garcia S; Maniu C; Pershad A; Abdullah SM; Hastings JL; Kumbhani DJ; Luna M; Addo T; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2015 Sep; 27(9):393-400. PubMed ID: 26332874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Clinical and Angiographic Outcomes After Bare Metal Stents and Drug-Eluting Stents Following Rotational Atherectomy.
    Tamura H; Miyauchi K; Dohi T; Tsuboi S; Ogita M; Kasai T; Okai I; Katoh Y; Miyazaki T; Naito R; Konishi H; Yokoyama K; Okazaki S; Isoda K; Kurata T; Daida H
    Int Heart J; 2016; 57(2):150-7. PubMed ID: 26973257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.